drugset / Trial / NCT04088305

Vancomycin Dosage Strategy Based on a Trough Concentration Model

NCT04088305

Phase 4 Completed 66 enrolled Peking University Third Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Study design: Allocation: Randomized Endpoint classification: Efficacy study Masking: Open label Primary purpose: Treatment Primary endpoint: Incidence of reaching the target serum trough concentration Secondary endpoint: Clinical efficiency, Antibiotic use, acute kidney injury.

Timeline

Start
2019-10-01
Primary completion
2022-05-31
Completion
2022-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Vancomycin Other / unclassified